^
BIOMARKER:

KDR overexpression

i
Other names: KDR, CD309, FLK1, VEGFR, VEGFR2, Kinase insert domain receptor (a type III receptor tyrosine kinase)
Entrez ID:
Related biomarkers:
KDR overexpression
GBM
bevacizumab + erlotinib
Resistant: C3 – Early Trials
KDR overexpression
HCC
bevacizumab + atezolizumab
Sensitive: C3 – Early Trials
KDR overexpression
GBM
bevacizumab
Resistant: C3 – Early Trials
KDR overexpression
Breast Cancer
sunitinib
Sensitive: C4 – Case Studies